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Since the discovery of Borrelia recurrentis  as a  cause of relapsing fever (1), biologists 
have been intrigued by the ability of the organism to cause repeated attacks of disease 
in  man.  Early  investigators  attempted  to  elucidate  the  relapse  phenomenon  by 
comparing  the  serologic  responses  of recovered  animals  with  original  and  relapse 
populations of spirochetes. Most found that peak antibody titers to relapse spirochetes 
subsequently appeared in the order in which the spirochete populations were isolated 
(2). This finding suggested that the surface antigens of the organism had been changed 
and that growth of a modified population was responsible for each relapse. However, 
this  concept  was  not  uniformly  accepted.  Some  investigators  could  not  detect  an 
immune response with  any serologic test  then  in  use.  As explained  in  a  review by 
Schuhardt  (3), there were many reasons for controversy about early theories on the 
mechanisms of relapse. Many strains studied had been grown by repeated passage in 
animals without  a complete record of factors that affected the relapse phenomenon. 
A  variety of tests were  used  to  measure  serologic  responses,  and  there  was  serious 
disagreement about which tests gave valid results.  In addition, the phenomenon was 
different in the many animal hosts used to study the process. 
In recent years, little progress has been made in elucidating the true nature of the 
phenomenon.  According  to  one  popular  concept  (3,  4),  new  serotypes  arise  from 
borreliae  that  escape the  specific antibody  response  and  retreat  into  organs where 
new  antigens  are unmasked.  These changed  organisms penetrate  the blood stream 
and  cause  a  relapse  that,  in  turn,  is  terminated  when  the  host  produces  a  specific 
serologic  response to  that  relapse  population.  This  process  is  repeated  until  death 
intervenes or a complete immunity is established. 
The development of a medium for cultivating borreliae (5, 6) and the demonstration 
by Coffey and Eveland  (7, 8)  that individual organisms in a  relapse population can 
be identified by specific fluoresceinated antiserum could have enabled new approaches 
to a  study of the phenomenon.  Investigating the  relapse phenomenon  in  rats,  they 
identified  four serotypes of B.  hermsii with  rabbit  and rat  antisera conjugated  with 
fluorescein-isothiocyanate  (FITC) 1 according  to  a  modification  of the  method  of 
Gordon et al.  (9).  Initially, we attempted to repeat their work with antisera prepared 
in  rabbits against  the original  and  three  relapse populations  of B.  hermsii obtained 
from a  single  mouse.  Borreliae  in  smears  of mouse  blood  were  stained  with  these 
antisera by indirect  immunofluorescence, but organisms from one population could 
not be clearly distinguished from those of the other three. Furthermore, the variability 
* Retired from the U. S. Public Health Service. Current address: 1102 S. 2nd, Hamilton, MT 59840. 
1  Abbreviations used in this paper: FITC, fluorescein-isothiocyanate; PBS, phosphate-buffered saline; PI, 
postinoculation; RML, Rocky Mountain Laboratories. 
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in  brilliance  among  individual  organisms  suggested  that  the  original  and  the  three 
relapse populations  contained  mixtures of serotypes.  From  preliminary studies  made 
with  cloned  populations,  it  became  apparent  that  the  relapse  phenomenon  was 
extremely  complex,  and  it  involved  many  more  than  four  serotypes  identified  by 
Coffey and  Eveland  (7, 8).  In this report,  the procedures  for isolating and  identifying 
serotypes and  observations on the dynamics of seroconversion  are described. 
Materials  and  Methods 
B. hermsii.  The HSI strain of B. hermsii used was isolated from Ornithodoros hermsi collected 
near Spokane, WA by Dr. Willy Burgdorfer (Rocky Mountain Laboratories  [RML]),  (10). 
Mice.  Most  experiments  involving animals  were conducted  on  18-19-d-old  Swiss mice of 
the RML stock. Mature female mice, 6  7-mo old (nonproductive breeding stock), were used for 
preparing antisera to various serotypes. BALB/c nu/nu mice of the RML substrain were used in 
experiments conducted  to evaluate the role of antibody  on conversion of serotypes.  All mice 
were inoculated intraperitoneally. 
Cloning of B.  hermsii and Preparation of Pools of Live Antigens.  After it  became  obvious  that 
relapse populations  initially studied contained mixtures of serotypes, a  cloned population  was 
established  from a  mouse that  had been fed upon by an infected O. hermsi tick. The organisms 
in  freshly  drawn  citrated  mouse  plasma  were  counted  (11),  and  then  12  mice  were  each 
inoculated intraperitoneally with 0.1  ml of a suspension containing five organisms per ml. Mice 
were usually  inoculated at  4:00 p.m.  on a  given day,  and  then their blood was examined for 
spirochetes 88  90 h later. For this examination, a small amount of blood, obtained by tail clip, 
was placed on a glass slide adjacent to an oval deposit of Kelly's medium (5). As the tail touched 
the slide, it was moved toward the medium until the blood moved into the edge of the medium. 
When  the slide was  placed  in a  warm  dark-field  condenser,  the drop  of blood would spread 
near the surface of the medium. Spirochetes were readily visible near the spreading edge of the 
blood and between clumps of erythrocytes. The minimum level of spirochetemia detectable by 
this  method  was  ~3  X  10  a organisms/ml.  The  three  mice that  developed the greatest  spiro- 
chetemia were bled, and glycerol was added to a  10% concentration to the individually citrated 
plasma  of two  mice and  frozen by submerging  vials  in  alcohol  at  -68°C.  Throughout  these 
experiments,  phosphate-buffered  saline  M/15,  pH  7.3  (PBS)  was  added  to equal  50%  of the 
volume of blood  taken  by cardiac  puncture,  to  increase  the yield of borreliae  in  the  plasma 
after centrifugation to remove blood cells. Starling with plasma of the third  mouse, we made 
3-4 passages  at  36-48-h  intervals in increasing numbers  of mice to obtain sufficient stocks of 
live organisms.  Plasma  of mice  with  the  greatest  spirochetemia  was  used  for  each  passage. 
Passages in which a  marked increase in spirochetemia was not achieved were excluded. Stocks 
of  organisms  made  after  the  first  four  batches  were  prepared  in  mice  given  300  nag  of 
cyclophosphamide/kg  body  weight  (Cytoxan,  Mead  Johnson  &  Co.,  Evansville,  IN)  1  2  h 
before inoculation with borreliae. 
Search for Serotypes and Preparation of Conjugated Antisera.  In an initial attempt  to recover new 
serotypes, we inoculated six mice with ~ l0  s organisms of the first cloned population  (type  1), 
and  the  infection  was  monitored  by  dark-field  microscopy.  Relapse  populations  from  this 
experiment and others were compared with each other by reciprocally staining organisms with 
their antisera. Each relapse population was cloned before stocks of organisms were prepared for 
immunization  of mice.  12  female  mice,  6-7  mo  old,  were  each  inoculated  with  ~2  ×  106 
borreliae.  After 36-40  h  post-inoculation  (PI),  these mice had  access only to drinking  water 
containing 600 mg of chlortetracycline hydrochloride/liter of water. This treatment  prevented 
growth of variants  in the blood stream, which could arise from the population  sequestered  in 
the brain.  Beginning on  the 6th  d  after  inoculation  and  repeated  four times at  3-d  intervals 
6  7  thereafter, each mouse received a booster dose of~2  X  10'-10  organisms of frozen stock. Most 
organisms were viable. 6 d  after the last booster dose, mice were bled by cardiac puncture.  As 
mice were  bled,  PBS  was  added  to  equal  50%  of the  volume of blood  obtained  from  each 
mouse. The resulting serum was considered to be a  1:2 dilution. 
Except  for the  following modifications,  the  procedure  of Peacock et  al.  (12)  was  used  for 
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reagents prescribed was reduced by one-half. Also,  FITC was allowed to couple with immu- 
noglobulins during incubation for 2 h at 35°C, instead of 45 min at 37°C. Conjugated antisera 
and working dilutions thereof were stabilized with bovine albumin added to a 1% concentration 
(13). Reserve stock conjugated antiserums were kept frozen at -68°C, and working quantities 
of undiluted and diluted sera were held at  4°C.  Antisera were diluted so that  homologous 
organisms stained brilliantly and  heterologous organisms stained  faintly (see Fig.  1).  This 
staining procedure enabled calculation of the  percentage of homologous and  heterologous 
organisms stained by each antiserum. If none of the organisms stained brilliantly,  the population 
was considered to represent a serotype(s)  other than those contained in the battery of antisera 
used in a  given test.  Because working dilutions gradually lost  activity when held at 4°C or 
when exposed  to room temperature, their concentration was periodically adjusted to achieve 
proper staining. 
Serotyping Borreliae in  Blood of Mice.  Spirochete  populations in  mice  were  characterized 
according to serotype by the procedure outlined (Table I). For the preparation of good slides, 
it is important that sufficient blood cells are taken into a capillary pipette and mixed with the 
plasma, so that, when the mixture is spread, ~25-50% of the glass slide will be covered with a 
single layer of erythrocytes. 
Media. During the early part  of the study, borreliae were cultivated in modified Kelly's 
medium (11) and suspended in this medium during cloning procedures. After we discovered 
that serotypes grown in this medium rapidly lost ability to express  their characteristic surface 
antigens and that the viability of small inocula was not well protected, further modifications 
were made by adding CMRL tissue culture medium to a 5% concentration (330-1540; without 
glutamine and sodium bicarbonate, Gibco Laboratories, Grand Island Biological Co., Grand 
Island, NY). This supplement was evaluated because it had been used for cultivating  Spiroplasma 
mirum, a fastidious organism (14). Also, yeastolate (Difco Laboratories, Detroit, MI) was added 
to a 0.2% concentration (6) to the complex medium hereafter termed fortified Kelly's medium. 
It should be noted that CMRL medium gradually lost  its ability to enhance growth as the 
shelf-life expiration date neared (6 mo). Because a precipitate formed when these supplements 
were mixed with Kelly's basal medium, the final medium was filtered through a coarse  filter 
before it was used to count borreliae for cloning. 
In  the  interest  of clarity,  some  special  procedures  used  in  experiments concerning the 
dynamics of antigenic variation are given in the Results section with the experiments concerned. 
Results 
Establishing  Battery of Serotype Antigens  and FITC-conjugated  Antisera.  The first three 
relapse populations of one mouse were cloned and then compared with the original 
and with  each  other by reciprocally staining blood smears of each  with  their  four 
FITC-conjugated antisera. By the  foregoing procedure, we showed  that  this mouse 
had been infected with at least four serotypes. By similarly examining the remaining 
relapse populations from the first experiment, six were shown to be types 1, 2, 3, or 4 
or mixtures thereof, but five contained populations other than the serotypes so  far 
identified. These five were then cloned, FITC-conjugated antisera were prepared, and 
each was compared with the rest and shown to be different. As new serotypes were 
identified, antisera were prepared against them, and their relapse populations were 
studied for additional new serotypes. The search was discontinued when 24 serotypes 
were identified. 
With the battery of 24 specific antisera, we  then determined the order  in which 
conversions occurred and whether a variant would regain its original surface antigens 
through a series of conversions. In this experiment and in all subsequent experiments 
involving defined inocula, counts were made of borreliae derived from freshly-drawn 
citrated blood of mice taken 24-44 h after inoculation. This time limit was selected to 
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FIG.  1.  (A)  Pure population of type 7 stained with its homologous antibody.  (B) Type 3 contam- 
inant  in  an  otherwise  pure  type  7 population  stained with  type 3  antibody.  (C)  Homologously 
stained type 21, connected with a thread-like extension. (D) Mixed population of types 4, 7, and  17 
stained with type 4 antibody. Type  17 cross-reacts with type 4 antibody. HERBERT G.  STOENNER,  THOMAS DODD,  AND CAROLE LARSEN 
TABLE I 
Procedure  for Serotyping Borreliae in Blood of Mice 
1301 
Clip tail of mouse, beginning 48 h PI and examine blood by dark-field 
A 
I.  If  10  6  borreliae/ml  estimated,  obtain  citrated 
blood by cardiac puncture. 
2.  Centrifuge blood, prepare slide of plasma, and 
fix in absolute methanol for 30 min at 35°C. 
3.  Stain with FITC-conjugated antisera for 30 min 
at 35°C. 
4. Wash slide in PBS for 7-8 min. 
5.  Read  slides under  Orthoplan  microscope (E. 
Leitz, Inc., Rockleigh, N  J). 
B 
If insufficient  number  at  48  h,  repeat  dark-field 
examination at 72 h. 
If 106 borreliae/ml, follow A.  If borreliae are pres- 
ent,  but  still  insufficient,  transfer 0.1  blood  to 
amplifier mouse. 
Clip tail of amplifier mouse at 48 h PI and examine 
blood by dark-field. If 106 borreliae/ml, follow A. 
If insufficient,  repeat  dark-field  examination  at 
72 h, then follow A. 
inoculated with 25 organisms, borreliae were regularly seen in their blood on the 3rd 
and  4th  d  PI (and  sometimes on the  5th),  and  clearance  of the original  population 
was usually precipitous. During preliminary studies we showed that the first antigenic 
change was associated with clearance of the original  population  from the blood and 
was not related  to the occurrence of relapse.  Therefore, on the 6th and  7th d  PI, 0.1 
ml  of blood  was  transferred  from  each  of the  12  test  mice  to  a  normal  mouse  to 
amplify the population for characterization by fluorescent antibody (FA) tests (Table 
I).  Blood from mice with  no detectable  spirochetemia  was also passed  to amplifier 
mice. In a  few instances,  the type inoculated into the test mouse persisted on the 6th 
d,  but  generally  the  population  present  on  the  6th  and  7th  d  were  first  relapse 
organisms. 
Staining Properties and Serologic Relationships.  Each serotype was stained specifically by 
its homologous antibody, and most were readily distinguished from the other 23 (Fig. 
1).  Homologously  stained  organisms  appeared  thicker  in  diameter  and  frequently 
contained brilliantly  stained  knobs or enlargements.  Some had what appeared  to be 
long extensions of axial filaments, perhaps one-quarter the diameter of the rest of the 
organisms. These extensions were frequently seen in smears of cultures.  In dark-field 
preparations,  two separate  organisms joined  by these  faintly visible extensions  were 
found  to  move  simultaneously  in  the  same  direction.  Sometimes  the  specifically 
stained  component of the organism would be spread  over an  area  15-30/~m  Diam, 
with  the skeletal  remains  of the organism  in  its  midst.  A  few cross-reactions caused 
some initial  difficulty in identifying serotypes until  they were recognized and evalu- 
ated by studying mixtures of the two organisms concerned. These cross-reactions were 
typically 2 plus in brilliance,  compared with a  5 plus homologous reaction  (Table II, 
Fig.  1).  Generally, cross-reactions were more pronounced in organisms situated  near 
the  periphery  of the  drop  of antiserum,  and  less prominent  in  smears  that  had  too 
many erythrocytes. A  troublesome one was a  serotype that commonly emerged from 
type 7 (Tables  II and III) and consequently was immunologically different.  Serolog- 
ically,  this  type  showed  extensive  cross-reaction  with  7  and  16  antibody.  Yet  no 
reaction  was seen  between  types  7 and  16  in reciprocal  tests  of these organisms and 
their  respective  antisera.  This  new  serotype  was  presumed  to  be  present  when  the 
same percentage of organisms were moderately stained with  7 and  16 antisera. 
Order of Emergence of Serotypes and Frequency of Their Occurrence.  On the 6th and 7th d 
after inoculation with 25 borreliae, 60% of mice had detectable spirochetemia;  yet, as 1302  ANTIGENIC  VARIATION  OF  BORRELIA HERMSII 
TABLE  II 
Serologic Relationships among 24 Serotypes of B. hermsii, as Detected by Reczprocal Fluorescent Antibody Tests 
Fluorescenl  Organisms 
antibody  1  2  3  1  5  6  7  8  9  10  II  I2  13  14  15  16  17  18  19  211  21  22  23  24 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
25 
16 
17 
18 
19 
20 
21 
22 
23 
24 
5* 
5 
5 
5 
5 
5 
5  (4)~; 
5 
5  2 
5 
2  5  2 
2  2  2  a 
22  5  '2 
(4)~  5 
5  2 
5 
2 
5 
5 
2  5 
2  5 
2  2  5 
* Numerals indicate level  of reaction  Blank spaces  indicate no reaction beyond background s a  g 
:~ Denotes new serotype that cross  reacts  with 7 and  16:7 and  16 do not cross  react  with each othel. 
judged  by blind  passage,  nearly  all  mice  were  spirochetemic.  Of a  potential  of 476 
mouse-days of observation  (288 mice on days 6 and 7), emerging types were identified 
on  419  mouse-days;  results  on  other  days  were  invalidated  because  mice  died  of 
cardiac  puncture  on day  6  or growth  of borreliae  in  amplifier  mice  was  inadequate 
for typing. There was considerable variation in the number of serotypes that emerged, 
but many of the less  frequent  of the longer lists  were represented  by only one or two 
isolates.  The  results  of these  experiments  indicate  a  wide  variation  in  frequency  of 
occurrence  of  types  (Table  III).  In  order  of  decreasing  frequency,  the  ten  most 
common serotypes encountered  were  7, 2,  17, 24,  13, 3,  1, 21,  11, and  12.  During 419 
mouse-days  on which  emerging  types were satisfactorily  identified,  types  7,  2,  13,  3, 
21, 4, and  14 were seen 313,  175, 80, 42, 41, 39, and 31  times, respectively.  These data 
suggest  that  conversions  do  not  occur  at  random,  but  are  programmed  in  some 
manner. Indeed, this thesis was supported by the results of three repeated experiments 
in which some minor serotypes were regularly  dominant  among the emerging  popu- 
lation  of selected  ones.  Thus,  4  commonly  emerged  from  15,  and  13  from  23  (Table 
III). 
Population  Changes During Antigenic  Conversion.  The next experiment  was conducted 
to  establish  the  population  changes  associated  with  conversion.  In  this  experiment, 
15-18  mice  were  each  inoculated  with  one  organism  of types  7,  3,  or  21  and  then, 
beginning  on  the  4th  d  PI,  0.15  ml  blood  was  obtained  daily  by cardiac  puncture 
from each  of 12 spirochetemic  mice.  0.10  ml was passed  to an  amplifier  mouse,  and 
0.05 ml was used for counting the organisms  (11).  If the plasma was relatively  free of 
lipids,  populations  as low as 800 cells/ml  blood could be counted,  but  in  most  cases 
borreliae  could  not  be  counted  accurately  in  dilutions  below  1:2  (1,600  cells/ml). HERBERT G.  STOENNER,  THOMAS  DODD,  AND  CAROLE LARSEN  1303 
TABLE III 
Serotypes Emerging During the First Relapse Period (Days 6 and 7) PI in Mice Inoculated with 25 
Organisms of a Given Serotype 
Scrotype  (~)rigin of 
inocu  "  Order of decreasing  frequency of emerging serotypes 
lated  serotype 
1  O. hermsi tick  7  2  17  24  20  14  13  9  1  (2 new) 
2  Exp*  I, MI  7  17  13  22  4  6  20  21  24  9  3  I  14  16 
3  Exp  I, MI  7  13  17  2  I1  7 ×  16:~  6  24 
4  Exp  1, M1  7  17  2  13  6  1  11  12  4  9  14  15  23  19 
5  Exp  1, MI  7  2  20  24  11  13  19  1  6  14  17  18  21  (2 new) 
6  Type  1  7  17  2  24  3  1  16  21  (1  new) 
7  Type 3  21  2  7 ×  16:~  17  24  11  I  6  20  19  18  14  (2 new) 
8  Exp  1, M3  7  17  24  21  13  3  22  1  2  20  18  19  14  15  6  (4 new) 
9  Exp  l, M5  2  7  24  12  1  21  14  16 
10  Exp  1, M6  7  24  2  17  21  1  3  10  12  9  13  16  18 
I 1  Exp  1, M2  7  24  17  2  11  13  20  21  14  8  2  3  (4 new) 
12  Exp  1, M3  7  17  24  2  10  14  16 
13  Type 4  3  17  7  2  4  21  22  24  1  8  14  16  18  20  (1  new) 
14  Type  7  17  7  12  24  4  2  10  7 ×  16:~  20  11  1  21  9  3  (3 new) 
15  Type 8  4  7  2  23  13  14  3  20  21  18  17  16  6  9  19  8  (4 new) 
16  Type 7  7  24  2  20  17  11  16  6  14 
17  Type9  7  2  13  11  6  15  17  12  14  1  4  16  18  21  24 
18  Type6  17  13  7  15  12  8  3  2  1  (1  new) 
19  Type 5  7  2  13  6  1  5  11  17  24  3  4  I9  21  (1  new) 
20  Type  1  7  17  24  14  2  3  21  i3  (10 new) 
21  Type  17  7  2  12  17  7 ×  16:~  1  9  11  8  13  14  (1  new)§ 
22  Type  15  7  17  2  21  18  14  3  8  13  1  16  6  9  20  24  (1  new) 
23  Type 4  13  7  4  2  24  17  12  16  20  1  6  9  14  10  19 
24  Type 5  7  8  17  2  3  13  16  6  9  20  (5 new) 
* Experimel~t, 
z~ New se'o ype tha  cross-reacts  strongly with 7 and  16. 
§ Emerging serotypes not tested against type 24 antiserum. 
Only  representative  findings  are presented  (Table  IV)  because data are too volumi- 
nous and population changes of some mice were not completely defined, as some mice 
died from repeated cardiac puncture. 
After inoculating mice with a single organism (or statistically,  very few)  (15),  most 
had developed spirochetemia on the 4th d  ranging from  10,000  to 800,000  borreliae/ 
ml (Table IV).  Infections in mice with low counts usually had not reached a peak by 
the 4th  d,  and the number of organisms increased  until the 5th  d.  On the 4th d  PI, 
most mice had a pure population of the inoculated serotype, but, in some, conversion 
had begun;  a  few mice still had a  pure population on the 5th d. A  prominent feature 
of the  initial  conversion  was a  sudden  clearance  of an  apparently  pure  population, 
from which as many as seven serotypes emerged the following day. In a special effort 
to  detect  small  numbers  of  emerged  types  among  organisms  during  peak  spiro- 
chetemia,  we  examined  as  many  as  3,000  borreliae  in  many  amplifier  mice,  but 
emerging types were rarely found. Thus, it appeared that only a small fraction of the 
population at any given time converted, and the event was coordinated with destruc- 
tion  of the  initial  population,  presumably  by  antibody  produced  by  the  host.  Note 
that  emerging serotypes generally  did  not persist  in the blood of mice for >2  d,  if a 
significant  population of that serotype developed  during that  period. 
Mechanisms of Conversion.  Two hypotheses about the mechanism of conversion were 
considered  in  planning  further  experiments.  Because  of the  sudden  change  from  a 
pure population to a  mixture of as many as seven serotypes  (Table  IV),  it appeared 
that the event may be induced by early antibody production; the alternative hypoth- 1304  ANTIGENIC VARIATION OF  BORRELIA HERMSH 
TABLE IV 
Population Changes among Serotypes of B. hermsii Undergoing Conversion in Mice Inoculated with One Organism 
of a Given Serotype 
Serotypc  Number of borrcliac o1' indicated scrotypes/m[  blood on day P[ 
Mouse  inocu- 
lated  4th  5th  6th  7th  8th 
,I I-m I  7  7(240,000)  I (800). 2(20), 6(200),  I (22,800), 2(7,600).  2(160,000). 7 x  14(<80). 17(<720) 
7 X  16'(2(X)).  6(3,800), 7 X  16(320.0(1(}), 
24 (800)  16  (7,600),  17  (16,000), 
13(15,200),  24( 1,2BO,O(X)) 
17(3,800), 24(7,600) 
Jbm3  7  7080,0OO)  I(100), 2(200), 6(600),  7 x  16(6,000),  21(7,000), 24(133,000)  2(40). 9(40), 12(200), 
7 x  16(1,200)  24(6,000)  17(3,600) 
J2-m2  7  7(60,000)  7(840,000)  7 x  16(8,0(X})  2(40,000), 7 X  Ncw (8,000) 
16(44,000), 21 (4,400) 
J3-m3  7  7(720,000)  7(800,000)  2(<2.000), 7 x  2(2,000), 7 x  14(41Y0). 17(3.60(I), 
16(< 1,600).  16 (8,000),  14 (2,000).  21 (2(S)) 
21 (<200), 24(<200)  17  (8,(RIO), 21 (2,(Xl~)) 
j1  m2  3  3(128,(K)0)  3(520,000)  2(<240), 7 ×  7 X  16(<1,600)  7(14,(R)0) 
16(<320), 24(<240) 
Jl  m3  3  3(440,000)  1(7,200),  2(7,200),  2(24), 7 X  16(I,480),  7 X  16(<1.600)  7 X  16(I.600) 
3(706,600)  24(720) 
J2-m2  3  3(56,000)  2(400), new (3.600)  2(6,600), 7(6,600),  20(35,000)  17(4,800) 
20(12,000), 
24(105.600) 
JI-ml  21  7 X  16(20,000),  7 X  16(16,000)  2(480), 12(320)  2(100.0(RI),  12(I00,000)  5(640), New (120) 
21 (380,000) 
Jl-m4  21  21(360,000)  7 x  16(<1,600)  1(<16), 2(<40),  6(600), 7 x  16(8,400),  7 x  16(800) 
6(<80), 7 ×  I2(8,400), 14(600), 
16(<240), 12(<240),  17(240), 24(600) 
14(<40), 17(<40) 
J2-m5  21  21(16,000)  21(400,000)  7 ×  16(160), 12(320),  7 ×  16(14,000),  7 x  I6(22,000), 
24(960)  12(t5,1300)  12(6.600). 
I 7(15,400) 
* New serotype that cro~s-reacts  strongly with 7 and  16. 
esis was that the event occurred spontaneously, independent  of antibody production. 
Because  small  numbers  of new  serotypes  could  be  present  but  obscured  at  peak 
spirochetemia, it became necessary to determine the generation time before the shift 
in population could be evaluated. For serotype 7, whose growth rate is representative 
of many others, the generation time was ~3 h  (2.8-4.2)  during logarithmic growth in 
na'l've mice  (16).  Thus,  in  most  cases  (Table  IV),  it  would  be  impossible  to  detect 
small numbers of newly emerged serotypes among an apparently pure population at 
peak spirochetemia. For example (type 7, J 1-ml), only 3 type  1 organisms are needed 
on day 4  to account for 800 on day 5, and it is impossible to detect  that  few among 
240,000  type  7.  However,  a  number of exceptions  were  noted  (not  all  shown).  For 
example,  one  should  have  been  able  to  detect  156  type  2  organisms  among 8,000 
(type 7 X  16 third line J2-M2)  on day 6  that would be needed to account for 40,000 
on day  7.  Hence,  further evaluation of the role of antibody  in conversion appeared 
necessary. 
Role of Antibody Production  in  Induction  of Conversion  of Borreliae.  This  question could 
be resolved readily by comparing the conversion rate of borreliae in nude mice with 
that  in  normal  mice,  if antibody  production  to  antigens  of borreliae  was  thymus 
dependent.  However, conversion did occur in nude mice inoculated with one type  7 
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was  10-fold lower than  in RML  mice. Because this approach  failed, alteration of the 
immune  response by chemical suppression  was attempted. 
In  preliminary  studies  (H.  Stoenner,  unpublished  observations),  we  showed  that 
cyclophosphamide (300 mg/kg) would usually delay clearance of the initial population 
by ~36 h. If early antibody production  directly influenced conversion, the number  of 
variants  in a  population just  before clearance of organisms  in the controls should  be 
much  lower in cyclophosphamide-treated  mice (17).  However, to isolate and  identify 
variant  organisms  in  either group,  it  would  be necessary  to eliminate  the  dominant 
population.  For  this  purpose,  antibody  specific  to  serotype  7  was  prepared  by 
inoculating adult  mice with ~5  X  106 organisms and treating each of them 48 h  later 
with  25,000  U  of penicillin  G  per  mouse,  given  intraperitoneally  (sodium  salt  of 
benzyl  penicillin).  3  d  later  mice  were  bled  and  serums  were  pooled  and  filtered 
through  a  0.2-#m  filter  to  remove  any  borreliae  that  may  have  survived  penicillin 
treatment. 
Cyclophosphamide  (300  mg/kg)  was administered  intraperitoneally  to eight  mice, 
and  2  h  later,  these  and  eight  control  mice  were  each  inoculated  with  one  type  7 
organism  (Table V). About  100 h  later,  the organisms  in plasma of l0 mice with the 
greatest spriochetemia  (5 principal and 5 control)  were counted and varying numbers 
TABLE  V 
Effect of lmmunosuppression of Mice on Conversion of Type 7 B. hermsii* 
Mouse number  Organisms/ 
ml plasma 
Variants that grew in amplifier mice inoculated 
with the following doses: 
100,000  10,000  1,000  333 
Cyclophosphamide- 
treated 
1  6.8  ×  106  24, 7  X  16:~  24,  7  ×  16  24  0 
2  8 X l04  ND§  24  0  0 
3  1 ×  10  7  24, 2, 20, 17, 7 ×  16  14  24, 2  0 
4  4×  l06  20,7×  16,2  20,17,6,7×  16  20, 2,7×  16  0 
5  1.8 ×  105  ND  24  24  0 
6  8.4 ×  l06  24, 20, 2, 7 ×  16  24  0  0 
7  8×  l05  24,  17,7×  16  0  0  0 
8  8.6 ×  l06  24, 2  24, 2  0  0 
9  7.2 x  l06  24  24  0  0 
10  1 x  106  2, 24,  7 x  16  0? H  2  0 
Controls 
1  3.6 x  106  20, 24, 6,  17, 2  24, 2,  7  ×  16  0  0 
2  4.8 ×  106  2, 24  0  0  0 
3  1.0 ×  l0  T  6, 20, 24, 2, 7 ×  16, 14  7 ×  16  7 x  16  0 
4  3.2 ×  106  24, 6  24  24  0 
5  2.2 ×  106  2, 20, 24, 7 ×  16, 14  0  0  0 
6  1.2 x  l06  2, 24  24  0  0 
7  1.5 ×  l05  ND  24  0  0 
8  1.5 x  l0  s  24  24  0?  0 
9  2.4 X 106  2, 6, 21  2  0?  0? 
10  1.5 ×  106  24,  17, New  24, New  0  0 
* Mice were treated with 300 mg cyclophosphamide/kg 2 h before inoculation with one type 7 organism. 
New serotype that cross-reacts with 7 and  16. 
§ Not done. 
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were inoculated  intraperitoneally  into mice that  had  been  treated  ~ 1 h  before with 
0.2 ml of a  1:16 dilution of 5-d anti-7 serum  given by the same route.  The blood of 
test  mice was examined on the 3rd and 4th d  PI. Passage of 0.1  ml whole blood was 
made to amplifier  mice on the  first  day of spirochetemia.  Blood from all  the rest  of 
the mice was passed on the 4th  d, regardless  of spirochetemia.  This experiment  was 
repeated,  and the results of both are compiled  (Table V).  The concentration of new 
serotypes varied among mice, but the number and types in cyclophosphamide-treated 
mice did  not  differ significantly from those  in control  mice.  Thus,  it  appeared  that 
early antibody did not markedly influence conversion. 
Spontaneous  Conversion  in  Cultures.  Next,  we  tested  the  hypothesis  that  conversion 
occurs spontaneously, independent of antibody. If it occurred in this manner, variants 
should  appear  in  cultures  of Kelly's  medium  inoculated  with  a  single  serotype.  It 
would have been ideal to initiate  growth from a  single organism, but  unfortunately, 
~800 were necessary to achieve growth  (11).  Nevertheless,  some preliminary  studies 
were made of types  1, 3,  7,  and  14 in Kelly's medium  inoculated with  mouse blood 
containing  ~ 106 organisms/inoculum.  During  the  first  culture  passage,  most of the 
organisms  of each  serotype  had  lost  ability  to  express  their  characteristic  surface 
antigen. A fluoresceinated antiserum was prepared against a cloned population of the 
changed organism  from type  7, and we were surprised  to learn  that  most organisms 
in cultures of these four serotypes now expressed a  common antigen  termed  "culture 
type." When these mixed cultures were inoculated into mice, the culture type persisted 
for  two  to  three  mouse  passages,  but  it  was  eventually  replaced  by  the  original 
serotype inoculated into the culture. 
Because plain Kelly's medium was not useful in resolving the question,  an attempt 
was made to improve the medium.  As CMRL  tissue culture medium  had been used 
to enhance growth of mycoplasma, a  fragile organism  (14), we attempted  to cultivate 
borreliae in this medium, but failed.  However, when it was added to a  5% concentra- 
tion  to  Kelly's medium  already  fortified  with  0.2%  yeastolate  (6,  11),  rapid  growth 
was  regularly  obtained  in  8.5-ml  culture  tubes  inoculated  with  a  single  organism. 
Furthermore,  most  of the  organisms  expressed  their  characteristic  surface  antigen 
during the first culture passage. 
Tubes of fortified Kelly's medium were then  inoculated with a  single organism  of 
type  7 obtained  from  freshly drawn  mouse  blood.  Cultures  were held  at  35°C  and 
monitored for growth, beginning ~ 13 d after inoculation. When it was estimated that 
maximum growth had been achieved, the population  in each tube was counted and 
mice were inoculated with varying numbers of borreliae. About 1 h before inoculation 
with organisms, mice were treated  with 0.2 ml of a  serum  mixture of a  1:16 dilution 
of anti-7  and  a  1:64 dilution  of anti-culture-type  serum  (unconjugated  serum  from 
hyperimmunized mice). This serum mixture, given intraperitoneally,  prevented infec- 
tion by the dominant  7 and any small numbers of culture type in the inocula. A 5-ml 
portion  of each  culture  was  centrifuged  to  sediment  organisms,  the  supernatant 
medium  removed  by aspiration,  and  the  sediment  resuspended  in  0.5  ml  of mouse 
blood diluted  1:5 in PBS. Slides of these suspensions were stained with fluoresceinated 
antisera  and  examined  for variant  serotypes.  A  similarly  designed  experiment  was 
conducted with type 21. 
The occurrence of variants  in cultures  originating  from a  single organism  is proof 
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TABLE  VI 
Spontaneous Conversion of B. hermsii, Type 7, in Tubes of Fort~ed Kelly's Medium Inoculated 
with One Organism 
Variants seen in 
Tube  Organisms/ml  smears of 
number  at harvest  cultures 
Variants that grew in mice* inoculated 
with the following doses: 
100,000  10,000  1,000  333 
I  1.36  x  106  24,  18, 17~:  17, 24, 2~:  24  24  0 
2  1.72 X  107  24, 20, 6  New, 2  0  0  0 
3  7.6 X  106  24  24, 20  24  24, 20  0 
4  1 ×  107  0  2, 6,  14, 20, 24  2, 24  24  0 
5  1.48 ×  107  24  20, 24, 6  20, 24  24  0 
6  5.2 ×  106  24, 6,  18  20, 24,  17, 2  17, 24  24, 20  24 
7  4 X  106  24  2, 6,  14, 17, 20, 24  20, 24  20, 24  0 
8  2 ×  107  24, 17  24, 20,  1, 17, 21  0  0  0 
* Before inoculation, mice were treated with 0.2 ml of mixed immune serum to type 7 (1:16 dilution) and 
to culture type (1:64 dilution), given intraperitoneally. 
:~ Listed in order of decreasing  frequency. 
TABLE  VII 
Spontaneous Conversion of B. hermsii, Type 21, in Tubes of Fort~'ed Kelly's Medium Inoculated 
with One Organism 
Tube  Organisms/ml  Variants seen in smears of 
nunlber  at harvest  cuhures 
Variants that  grew in mice* inoculated with the following doses: 
100,000  10,000  1,000  333 
1  4 ×  10  'J  24,  17,  12, 20, 2, 7:~  12, 24,  17, 7:~  IGFA§  24,  17,  12  24 
2  2.4 ×  107  24,  7,  12,  17  24,  17,  12, 7  12, 24,  17, 2  12  0 
3  2.4 ×  10  v  24,  7,  12, 9,  17  12,  17, 24  7, 7 ×  16, 24 2  7, 12  0 
4  3.2 ×  107  24,  12,  14, 7,  17, 2  24,  12,  17, 7,  14  12.24,  17,  14, 7  12, 24, 7  0 
5  I ×  107  12, 24, 2  24,  17,  12  24.  12, 2,  17, 7, 20  12, 24,  17, 7, 20  0 
6  I  ×  107  12,2,  17  12,  17,24  14  0  0 
7  4 ×  10  ~  24,  17, 22,  7  7,  12.2, 7 ×  16  12, 7,  14,  17  12,  14, 7, 24  14, 24 
8  2.8 X  107  24,  12,  17, 7, 2,  14,  15  12, 7, 7 ×  16,  17, 2  12,  17,  14, 24  12,  17, 24  17, 24 
* Before  inoculation,  mice were  treated  with  0.2  ml of mixed  immune serum  to  type  21  (1:16  dilution)  and  to culture  type  (1:64)  given 
int raperitoneally. 
~: Listed in order of decreasing frequency. 
§ Insufficient  growth for identification by FA staining. 
originating from type 7 was roughly comparable  to that seen in populations  grown in 
mice  (Table  V).  Furthermore,  the  variation  in  concentration  is consistent  with  that 
expected  in  a  spontaneous  change,  as  the  event  could  occur  at  any  time  during 
logarithmic growth. Tubes  in which the event occurred early would contain a  higher 
concentration  than  those  in which  the event occurred  late in  the growth  curve.  The 
number  and concentration  of variants in cultures of type 21 was higher than that seen 
in  cultures  of type  7.  However,  type  21  cultures  had  more  opportunity  to  convert 
because  the yield of organisms  at  harvest  was  greater than  that  of type  7 cultures.  In 
most instances, variants that appeared  in mice were also detected in smears of cultures 
that  had  been inoculated into mice. None of the tubes of cultures of type  7 or 21  had 
>1% culture type at  time of harvest  (data  not shown). 
Discussion 
Our  findings  on  conversion  and  its  dynamics  have  clarified  much  of  the  long- 
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B.  hermsii.  It is likely that spirochetemia in man, like  that  in mice, is persistent,  and 
that  relapses  are  diagnosed  when  populations  reach  detectable  levels.  Although 
borreliae will  persist  in  immunologically compromised sites  like  the  brain  and  eye, 
such sites are not essential for the spontaneous conversion of the organism and ensuing 
relapses caused by variants.  In past research,  much confusion arose because investi- 
gators assumed  that  relapse  populations consisted of a  single serotype. The finding 
that these relapse populations are frequently mixed explains the contradictory findings 
of early workers  (3), who contended that antibodies to borreliae could be measured 
by an  unusual  variety of serologic tests,  including agglutination, adhesion,  opsonic 
activity, immobilization, and spirochetolysis tests.  Those who contended that none of 
these tests  were of any value were probably right, because the antigenic composition 
of populations  would  change  during  a  brief series  of passages.  Furthermore,  the 
agglutinability of different  serotypes  varies.  As observed  in  darkfield  preparations, 
type 7 remains uniformly dispersed, whereas others, e.g.,  types 14,  16, and 21, adhere 
to each other and  blood elements  they contact. Organisms of these  types are often 
seen with their tails joined and bounding about the field in the form of a circle. 
The mouse antisera used in this study were remarkably specific. This characteristic 
has been recognized before in the identification of closely related strains of Rickettsia 
rickettsii  (18,  19). The specificity of antisera was not marked until mice had received 
three booster doses of organisms. Hence, they were given two additional boosters to 
assure  adequate  differentiation  of serotypes.  Probably one  reason  for  the  serotype 
specificity of these sera was that mice were immunized with living organisms whose 
surface antigens had not been altered by germicidal chemicals. For example, we found 
that  organisms  exposed  to  5%  formalin  for  30  rain  no  longer  reacted  with  their 
homologous antisera (H. G. Stoenner, unpublished observations). This finding suggests 
that  protein must be a  part of the antigens that characterize each serotype. Indeed, 
the differences among serotypes that we identified by serologic techniques have been 
confirmed in companion studies in which biochemical differences in antigenic struc- 
ture have been elucidated by other techniques (20). 
On the basis of current knowledge, it  is impossible to predict how often B.  hermsii 
can change its surface antigens. During experiments conducted to discover new types 
and to define serotypes emerging from each of the 24 types, 43 mice were eventually 
infected with new types.  Had these,  in turn,  been similarly studied,  additional  new 
serotypes would  likely  have  emerged  from  them.  One  is  impressed  with  the  large 
number of serotypes that may emerge from a given type (Table III), but it should be 
noted that some of those identified on day 7 may have emerged from variant  types 
that  arose early in  the  infection.  It should  also  be  noted  that  the  variation  in  the 
number of emerging types was, in part, affected by the amount of growth in indicator 
mice; more serotypes were usually recognized in mice with a heavy spirochetemia. 
Our  findings  on  spontaneous  conversion  in  cultures  also  indicate  that  a  large 
number of serotypes can emerge from a  single type. It is likely that all  11  serotypes 
seen in smears of eight cultures of type 21 arose from this type, but the possibility that 
some arose from type 24 or other more common variants cannot be firmly excluded. 
The ability of one type to change to many other types, and the fact that types 7 and 
21  both  commonly changed  to  24,  suggest  a  very complex  genetic  control  of the 
mechanism.  Our findings on spontaneous conversion late  in  this  study explain  our 
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three to four passages in mice. For example, passages were made of four clones of type 
16 before satisfactory antigen for immunizing mice was obtained. Unfortunately, in 
neither study on conversion were we able to calculate rates because we were unable 
to accurately count the number of variants in a  given population. Also, the number 
of variants that grew in amplifier mice was affected by some cross-neutralization by 
the antiserum  used to destroy the dominant population. Based on the prevalence of 
the variants, it was estimated that the rate was ~ 10-4-10  -3 per cell per generation. 
Our data do not suggest that B.  hermsii converted in any definite order. In fact, it 
is clear that type 7 is dominant and that variants commonly revert to 7 in the absence 
of antibody to this serotype. This observation, however, may not reflect what happens 
in nature,  because the organism in the tick from which the culture was started  was 
type  1.  Also,  type  7  was  not  found  in  a  spirochetemic  patient  from  Colorado. 
(Heparinized blood had been submitted by Dr.  I. M.  Baird, Columbus, OH, to Dr. 
Willy Burgdorfer, RML, for diagnosis.) This patient, presumably bitten by Ornithodoros 
hermsi,  had  a  mixed  infection  of  20,  24,  and  a  new  serotype  (H.  G.  Stoenner, 
unpublished  observations).  It  would  be  interesting  to  study  the  distribution  of 
serotypes in more human cases and in naturally infected ticks. 
The role of antibody in antigenic variation appears to be one of selection of variants 
and destruction of the dominant serotype population. The rate of antibody develop- 
ment in mice depends on the number of borreliae inoculated. We were able to detect 
serotype-specific immunoglobulin at 60 h PI, but not at 48 h, in mice inoculated with 
~106  borreliae  (H.  G.  Stoenner,  unpublished  observations).  However,  on  several 
occasions when we attempted to pass large inocula of serotypes at 48 h  intervals, we 
noted that, in a  single passage, a  nearly pure population of one serotype changed to 
a  mixture of variants that commonly emerge from that serotype. In these instances, 
we  thought  that  sufficient  antibody  had  developed  and  bound  to  the  dominant 
population to destroy it  in the next  passage.  In this regard,  it should be noted that 
mice infected with B. hermsii have a  marked lymphocytosis and consequently primed 
lymphocytes in a whole blood inoculum might alter the population during repeated 
passage. 
Although we  found that  conversion occurs spontaneously and  the  process is  not 
likely initiated by contact of the organism with early antibody, it appears that other 
host factors may be involved. For example, type 4 never emerged from types 7 and 3 
in mice, but did so in rats  (H. G. Stoenner, unpublished observations). When type 7 
was inoculated into rats, nearly every rat, on the day after initial clearance, was also 
infected  with  a  new  serotype  not  seen  in  mice.  In  experiments  on  spontaneous 
conversion, there was general agreement between variant types seen in cultures and 
those that appeared in mice (Tables V and VI), but there were exceptions. Also, some 
serotypes that appeared in mice inoculated with  1,000  organisms did not appear in 
mice that received a  10-fold greater dose (Tables VI and VIII, tube 3). In these cases, 
perhaps cross-neutralization  (for example,  Table  IV, J1-M3, 6th  d  inoculated with 
type 3) and varying rates of growth among serotypes determine which develop in the 
amplifier mouse. 
Summary 
At least  24 different serotypes were detected in populations of Borrelia hermsii that 
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specific fluoresceinated antisera prepared against cloned populations of living orga- 
nisms  of each  type.  In  the  order  of decreasing  frequency,  the  10  types  more  often 
encountered were  7, which was clearly dominant, and  2,  17,  24,  13,  2,  1, 21,  11,  and 
12. Each of the 24 types were shown to change to 7 or more other serotypes. 
Spirochetemia in mice was persistent, and relapses occurred when the concentration 
of organisms was sufficient for detection by visual means. After mice were inoculated 
with  a  single organism,  peak spirochetemia usually occurred  on  day 4,  after which 
clearance of organisms occurred, and an apparently pure population was replaced by 
a  mixed population consisting of as many as seven variants. These types persisted for 
2-3 d before being replaced by other types. Conversions occurred constantly and were 
independent of relapses. The rate of conversion in mice treated with cyclophosphamide 
to  delay  antibody  production  was  comparable  to  that  of  controls.  Spontaneous 
conversion was clearly demonstrated in tubes of fortified Kelly's medium inoculated 
with a single organism of type 7 or 21.  11 different variants appeared in eight cultures 
of type 21  by the time growth  had  reached  4  ×  10%107  organisms/ml.  The  rate of 
spontaneous change was estimated to be ~  10 -4-10 -a per cell per generation. 
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